Involvement of membrane-type bile acid receptor M-BAR/TGR5 in bile acid-induced activation of epidermal growth factor receptor and mitogen-activated protein kinases in gastric carcinoma cells.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  2007-03-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.BBRC.2006.12.168PMID 17214962
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation

  2006cited by this paper
• Bile acid-induced proliferation of a human colon cancer cell line is mediated by transactivation of epidermal growth factor receptors.

  2005cited by this paper
• ADAM-mediated ectodomain shedding of HB-EGF in receptor cross-talk.

  2005cited by this paper
• G Protein Coupling and Second Messenger Generation Are Indispensable for Metalloprotease-dependent, Heparin-binding Epidermal Growth Factor Shedding through Angiotensin II Type-1 Receptor*

  2005cited by this paper
• Elevated cyclooxygenase-2 expression in patients with early gastric cancer in the gastric pylorus

  2005cited by this paper
• Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1.

  2005cited by this paper
• A G Protein-coupled Receptor Responsive to Bile Acids*

  2003cited by this paper
• REVIEW: Activation of Muscarinic Receptor Signaling by Bile Acids: Physiological and Medical Implications

  2003cited by this paper
• The Stress- and Inflammatory Cytokine-induced Ectodomain Shedding of Heparin-binding Epidermal Growth Factor-like Growth Factor Is Mediated by p38 MAPK, Distinct from the 12-O-Tetradecanoylphorbol-13-acetate- and Lysophosphatidic Acid-induced Signaling Cascades*

  2003cited by this paper
• Bile acids activate EGF receptor via a TGF-alpha-dependent mechanism in human cholangiocyte cell lines.

  2003cited by this paper
• Cyclooxygenase‐2 and gastric carcinogenesis

  2003cited by this paper
• Metalloprotease inhibitor blocks angiotensin II-induced migration through inhibition of epidermal growth factor receptor transactivation.

  2002cited by this paper
• COX-2: a target for colon cancer prevention.

  2002cited by this paper
• Identification of membrane-type receptor for bile acids (M-BAR).

  2002cited by this paper
• G protein–coupled receptors

  2002cited by this paper
• Untangling the ErbB signalling network

  2001cited by this paper
• Deoxycholic acid (DCA) causes ligand-independent activation of epidermal growth factor receptor (EGFR) and FAS receptor in primary hepatocytes: inhibition of EGFR/mitogen-activated protein kinase-signaling module enhances DCA-induced apoptosis.

  2001cited by this paper
• Identification of a nuclear receptor for bile acids.

  1999cited by this paper
• EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF

  1999cited by this paper
• Dominant negative EGFR-CD533 and inhibition of MAPK modify JNK1 activation and enhance radiation toxicity of human mammary carcinoma cells

  1999cited by this paper
• Employment of the Epidermal Growth Factor Receptor in Growth Factor–Independent Signaling Pathways

  1999cited by this paper
• An essential role for ectodomain shedding in mammalian development.

  1998cited by this paper
• Dihydroxy Bile Acids Activate the Transcription of Cyclooxygenase-2*

  1998cited by this paper
• Hydrogen peroxide induces complex formation of SHC-Grb2-SOS with receptor tyrosine kinase and activates Ras and extracellular signal-regulated protein kinases group of mitogen-activated protein kinases.

  1996cited by this paper
• Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors

  1996cited by this paper
• Reflux of duodenal or gastro‐duodenal contents induces esophageal carcinoma in rats

  1996cited by this paper
• Ultraviolet radiation induces phosphorylation of the epidermal growth factor receptor.

  1994cited by this paper
• Stomach cancer after partial gastrectomy for benign ulcer disease.

  1988cited by this paper

• Using sodium glycodeoxycholate to develop a temporary infant-like gut barrier model, in vitro

  2025cites this paper
• Class A Orphans in GtoPdb v.2025.1

  2025cites this paper
• Bile acid receptor in GtoPdb v.2025.3

  2025cites this paper
• Class A Orphans in GtoPdb v.2025.4

  2025cites this paper
• Emerging Roles of Bile Acids and TGR5 in the Central Nervous System: Molecular Functions and Therapeutic Implications

  2024cites this paper
• Smooth muscle contractile responses to bile acids in mouse ileum require TGR5 but not ASBT

  2024cites this paper
• Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets

  2024cites this paper
• Oleanolic acid rescues critical features of umbilical vein endothelial cells permanently affected by hyperglycemia

  2023cites this paper
• The kidney drug transporter OAT1 regulates gut microbiome–dependent host metabolism

  2023cites this paper
• An Update of G-Protein-Coupled Receptor Signaling and Its Deregulation in Gastric Carcinogenesis

  2023cites this paper
• The Pathological Effects of Circulating Hydrophobic Bile Acids in Alzheimer’s Disease

  2023cites this paper
• The role of bile acid in intestinal metaplasia

  2023cites this paper
• Molecular orchestra of microbiotic metabolites in the scenario of carcinogenesis

  2023cites this paper
• Molecular Ensembles of Microbiotic Metabolites in Carcinogenesis

  2023cites this paper
• The role of bile acids in carcinogenesis

  2022influential citation
• Oleanolic acid stimulation of cell migration involves a biphasic signaling mechanism

  2022cites this paper
• Research on Gut Microbiota-Derived Secondary Bile Acids in Cancer Progression

  2022cites this paper
• Bile acid metabolism and signaling, the microbiota, and metabolic disease.

  2022cites this paper
• Effects of Intestinal FXR-Related Molecules on Intestinal Mucosal Barriers in Biliary Tract Obstruction

  2022cites this paper
• Beyond lipids: Novel mechanisms for parenteral nutrition-associated liver disease.

  2022cites this paper
• Lithocholic acid promotes skeletal muscle regeneration through the TGR5 receptor

  2022cites this paper
• The bile acid receptor TGR5 and cholestasis

  2022cites this paper
• The role of TGR5 as an onco-immunological biomarker in tumor staging and prognosis by encompassing the tumor microenvironment

  2022cites this paper
• Class A Orphans in GtoPdb v.2021.3

  2021cites this paper
• Bile Acids as Metabolic Inducers of Hepatocyte Proliferation and Liver Regeneration

  2021cites this paper
• Role of FXR in Bile Acid and Metabolic Homeostasis in NASH: Pathogenetic Concepts and Therapeutic Opportunities

  2021cites this paper
• Microbial Hydroxysteroid Dehydrogenases: From Alpha to Omega

  2021cites this paper
• Meta-Analysis Reveals the Prognostic Relevance of Nuclear and Membrane-Associated Bile Acid Receptors in Gastric Cancer

  2021cites this paper
• Gut microbial bile acid metabolite skews macrophage polarization and contributes to high-fat diet-induced colonic inflammation

  2020cites this paper
• Bile Acids and GPBAR-1: Dynamic Interaction Involving Genes, Environment and Gut Microbiome

  2020cites this paper
• Metabolite Sensing GPCRs: Promising Therapeutic Targets for Cancer Treatment?

  2020cites this paper
• Bile Acids as Signaling Molecules

  2020cites this paper
• Hepatoprotective impact of the bile acid receptor TGR5

  2020cites this paper
• TGR5 promotes cholangiocarcinoma by interacting with mortalin.

  2020cites this paper
• Bile acid receptor (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• Dimerization energetics of the G‐protein coupled bile acid receptor TGR5 from all‐atom simulations

  2019cites this paper
• Developments in bile salt based therapies: A critical overview

  2019cites this paper
• Bile Acid Receptors and Gastrointestinal Functions.

  2019cites this paper
• Role of the Gut–Liver Axis in Driving Parenteral Nutrition-Associated Injury

  2018cites this paper
• Intestinal targeting of small molecule MMP and TGR5 ligands for inflammatory bowel disease

  2018cites this paper
• The membrane bile acid receptor TGR5 drives cell growth and migration via activation of the JAK2/STAT3 signaling pathway in non-small cell lung cancer.

  2018cites this paper
• Activation of FXR promotes intestinal metaplasia of gastric cells via SHP-dependent upregulation of the expression of CDX2

  2018cites this paper
• Guts and Gall: Bile Acids in Regulation of Intestinal Epithelial Function in Health and Disease.

  2018cites this paper
• GPCRs and EGFR - Cross-talk of membrane receptors in cancer.

  2017cites this paper
• Bile acid receptor TGR5 overexpression is associated with decreased intestinal mucosal injury and epithelial cell proliferation in obstructive jaundice

  2017cites this paper
• Preserved Gut Microbial Diversity Accompanies Upregulation of TGR5 and Hepatobiliary Transporters in Bile Acid–Treated Animals Receiving Parenteral Nutrition

  2017cites this paper
• Bile acids and their receptors during liver regeneration: "Dangerous protectors".

  2017influential citation
• Bile acids and colon cancer: Is FXR the solution of the conundrum?

  2017cites this paper
• Bile salt receptor TGR5 is highly expressed in esophageal adenocarcinoma and precancerous lesions with significantly worse overall survival and gender differences

  2017cites this paper
• Clinical relevance of the bile acid receptor TGR5 in metabolism.

  2017cites this paper
• Durham E-Theses EXPRESSION OF ENDOPLASMIC RETICULUM OXIDOREDUCTASES (EROS) AND THEIR ROLE IN THE GI TRACT

  2017cites this paper
• ADAM17 promotes epithelial-mesenchymal transition via TGF-β/Smad pathway in gastric carcinoma cells.

  2016cites this paper
• Bile acids regulate intestinal cell proliferation by modulating EGFR and FXR signaling.

  2016cites this paper
• The bile acid receptor GPBAR1 (TGR5) is expressed in human gastric cancers and promotes epithelial-mesenchymal transition in gastric cancer cell lines

  2016influential citation
• Membrane bile acid receptor TGR5 predicts good prognosis in ampullary adenocarcinoma patients with hyperbilirubinemia

  2016cites this paper
• Oleanolic Acid Improves Gut Atrophy Induced by Parenteral Nutrition.

  2016cites this paper
• Bile Salts at Low pH Cause Dilation of Intercellular Spaces in In Vitro Stratified Primary Esophageal Cells, Possibly by Modulating Wnt Signaling

  2016cites this paper
• Therapeutic potential of Takeda‐G‐protein‐receptor‐5 (TGR5) agonists. Hope or hype?

  2016cites this paper
• Безпека застосування парацетамолу в клінічній практиці

  2016cites this paper
• TGR5 is essential for bile acid-dependent cholangiocyte proliferation in vivo and in vitro

  2015cites this paper
• Mutational mapping of the transmembrane binding site of the G-protein coupled receptor TGR5 and binding mode prediction of TGR5 agonists.

  2015cites this paper
• Formulations of deoxycholic for therapy: a patent review (2011 – 2014)

  2015cites this paper
• TGR5: Pathogenetic Role and/or Therapeutic Target in Fibrosing Cholangitis?

  2015cites this paper
• Activation of the bile acid receptor TGR5 enhances LPS-induced inflammatory responses in a human monocytic cell line

  2015cites this paper
• Bile Acids in Physiology, Pathology and Pharmacology.

  2015cites this paper
• Controversies in the Mechanism of Total Parenteral Nutrition Induced Pathology

  2015cites this paper
• TGR5 in the Cholangiociliopathies

  2015cites this paper
• Neuro‐humoral signalling by bile acids and the TGR5 receptor in the gastrointestinal tract

  2014cites this paper
• TGR5 ligands as potential therapeutics in inflammatory diseases

  2014cites this paper
• Bile Acids : Attractive Targets for Novel Therapeutics

  2014cites this paper
• TGR5 in inflammation and cardiovascular disease.

  2014cites this paper
• Differential Regulation of EGFR–MAPK Signaling by Deoxycholic Acid (DCA) and Ursodeoxycholic Acid (UDCA) in Colon Cancer

  2014cites this paper
• The bile acid TGR5 membrane receptor: from basic research to clinical application.

  2014cites this paper
• Bile acid dysregulation, gut dysbiosis, and gastrointestinal cancer

  2014cites this paper
• GPBA: a GPCR for bile acids and an emerging therapeutic target for disorders of digestion and sensation

  2014cites this paper
• Bile acid sequestrants in type 2 diabetes: potential effects on GLP1 secretion.

  2014cites this paper
• Bile acids in the colon, from healthy to cytotoxic molecules.

  2013cites this paper
• The Bile Acid Receptor TGR5 Does Not Interact with β-Arrestins or Traffic to Endosomes but Transmits Sustained Signals from Plasma Membrane Rafts*

  2013cites this paper
• Bile Acid at Low pH Reduces Squamous Differentiation and Activates EGFR Signaling in Esophageal Squamous Cells in 3-D Culture

  2013cites this paper
• The bile acid membrane receptor TGR5: a novel pharmacological target in metabolic, inflammatory and neoplastic disorders

  2013cites this paper
• The Concise Guide to Pharmacology 2013/14: G Protein-Coupled Receptors

  2013cites this paper
• ADAM17 is overexpressed in non-small cell lung cancer and its expression correlates with poor patient survival

  2013cites this paper
• Ciliary subcellular localization of TGR5 determines the cholangiocyte functional response to bile acid signaling.

  2013cites this paper
• Chemogenomics Approaches to Rationalizing the Mode-of-Action of Traditional Chinese and Ayurvedic Medicines

  2013cites this paper
• TGR5 in cholangiocytes

  2013cites this paper
• Role of Bile Acids in Carcinogenesis of Gastrointestinal Tract

  2012cites this paper
• Patented TGR5 modulators: a review (2006 – present)

  2012cites this paper
• Unifying mechanisms of action of the anticancer activities of triterpenoids and synthetic analogs.

  2012cites this paper
• Identificación de nuevos genes diana del receptor nuclear FXR

  2012cites this paper
• Prognostic value of ADAM17 in human gastric cancer

  2012cites this paper
• Chemoprevention of colorectal cancer with ursodeoxycholic acid: pro.

  2012cites this paper
• The Bile Acid Membrane Receptor TGR5: A Valuable Metabolic Target

  2011cites this paper
• Bile acids and colon cancer: Solving the puzzle with nuclear receptors.

  2011cites this paper
• Modulation of the activity of a key metabolic regulator small heterodimer partner by post-translational modifications

  2011cites this paper
• Metabolic surgery—principles and current concepts

  2011cites this paper
• The gut-to-breast connection - interdependence of sterols and sphingolipids in multidrug resistance and breast cancer therapy.

  2011cites this paper
• Role of TGR5 in Bile Acid Metabolism

  2011cites this paper
• The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation.

  2011cites this paper
• rsodeoxycholic acid and chemoprevention of olorectal cancer

  2010cites this paper
• Targeting the TGR5-GLP-1 pathway to combat type 2 diabetes and non-alcoholic fatty liver disease.

  2010cites this paper